|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02219 CHAOJU EYE CARE
Nominal 
2.500 -0.020 (-0.794%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 710,694 | 1.781% | 1,360,360 | 1,405,454 | 1,369,505 | 990,044 |
| Cost of Sales | (423,458) | 5.708% | (786,459) | (794,152) | (748,371) | (555,347) |
| Gross Profit | 287,236 | -3.504% | 573,901 | 611,302 | 621,134 | 434,697 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 119 | -- | (2,502) | (2,028) | (5,835) | (3,957) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (55) | -- | (11) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 125,660 | -17.918% | 256,099 | 262,723 | 299,242 | 239,138 | |
| Taxation | (32,724) | -22.731% | (78,691) | (76,513) | (78,507) | (55,942) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,784 | -38.567% | 6,037 | 8,866 | 8,179 | 4,556 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 94,720 | -16.651% | 183,445 | 195,076 | 228,914 | 187,752 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (7,631) | -38.251% | (21,228) | (28,930) | (29,085) | (11,077) |
| Depreciation & Amortisation | 72,352 | -1.834% | 148,238 | 144,161 | 123,361 | 99,366 |
| Directors' Emoluments | -- | -- | 6,348 | 6,664 | 6,013 | 4,323 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 14.000 | -12.500% | 26.000 | 28.000 | 33.000 | 27.000 |
| DPS (cts) | 0.000 | -- | 21.238 | 23.074 | 26.984 | 15.227 |
| Dividend Payout Ratio (%) | -- | -- | 81.684% | 82.405% | 81.770% | 56.396% |
| Cash flow per share ($) | -- | -- | 0.489 | 0.514 | 0.536 | 0.387 |
| NBV per share ($) | 3.294 | -- | 3.396 | 3.272 | 3.335 | 3.212 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 94,720 |
| %Change | -16.651% |
| EPS / (LPS) | RMB 0.140 |
| NBV Per Share (¥) | RMB 3.294 |